Tissue transglutaminase levels above 100 U/mL and celiac disease: A prospective study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

431

HTML

3814

Tables (1-2)

215

Sum=4460

Aug 28, 2012 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2012; 18(32): 4399-4403
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4399

Table 1 Results of small-intestinal biopsy and serology n (%)

		Biopsy data
		Patients n = 183 (100.0)	Patients with CD n = 120 (65.6)	Patients with normal histology n = 63 (34.4)
IgA EMA	Negative	47 (25.7)	4 (3.3)	43 (68.3)
	Positive	136 (74.3)	116 (96.7)	20 (31.7)
IgA tTGA > 10	Negative	53 (29.0)	4 (3.3)	49 (77.8)
	Positive	130 (71.0)	116 (96.7)	14 (22.2)
IgA tTGA ≥ 100	Negative	96 (52.5)	33 (27.5)	63 (100)
	Positive	87 (47.5)	87 (72.5)	0 (0.0)

CD: Celiac disease; IgA: Immunoglobulin A; EMA: Anti-endomysium antibodies; tTGA: Anti-tissue-transglutaminase antibodies.

Citation: Mubarak A, Wolters VM, Gmelig-Meyling FH, ten Kate FJ, Houwen RH. Tissue transglutaminase levels above 100 U/mL and celiac disease: A prospective study. World J Gastroenterol 2012; 18(32): 4399-4403
URL: https://www.wjgnet.com/1007-9327/full/v18/i32/4399.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i32.4399